{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-103316","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2026-08-28T21:11:48+00:00","discovered_at":"2026-08-28T21:14:05.100005+00:00","generated_at":"2026-08-28T21:14:10.154070+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Coherus Oncology enters ATM offering to sell up to $50M of common stock","bullets":["Sales agreement dated Aug 28, 2026 with Leerink Partners LLC for at-the-market sales of common stock.","Company may offer up to $50.0M aggregate gross proceeds; no obligation to sell any shares.","Agent commission up to 3% of gross proceeds; customary indemnification provided.","Proceeds intended for general corporate purposes including working capital.","Offered under S-3 shelf (effective Dec 8, 2025) with prospectus supplement filed Aug 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-103316","json":"https://secwatch.observer/filing/0001104659-26-103316.json","markdown":"https://secwatch.observer/filing/0001104659-26-103316.md","text":"https://secwatch.observer/filing/0001104659-26-103316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926103316/0001104659-26-103316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926103316/chrs-20260828x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T21:14:10.154070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}